Search
for

    Sort by

    Research 451–480 of 1000+

    1. Simultaneous determination of multi-class active pharmaceutical ingredients by UHPLC-HRMS Journal of pharmaceutical and biomedical analysis · 2021 · 2 citations
    2. Validated RP-TLC Method with Densitometry for Assay of Finasteride in Simple Pharmaceutical Dosage Form Current Pharmaceutical Analysis · 2018 · 2 citations
    3. Social Pharmacology: Integrating Pharmaceutical and Social Science Research on Drug Effects Drug Information Journal · 2004 · 2 citations
    4. The exposome impact on hair health: non-pharmacological management. Part II⋆ Anais Brasileiros de Dermatologia · 2025 · 1 citations
    5. LB1056 Phase 1b: Translational evaluation of VYN201, a pan-BD BET inhibitor, for the treatment of non-segmental vitiligo Journal of Investigative Dermatology · 2024 · 1 citations
    6. Non-pharmacological interventions for side effects of antineoplastic chemotherapy prioritized by patients: systematic review Revista CUIDARTE · 2024 · 1 citations
    7. Editorial: Synthesis, functionalization, and clinical translation of pharmaceutical biomaterials Frontiers in Bioengineering and Biotechnology · 2022 · 1 citations
    8. LB793 A phase 1, open-Label, single ascending dose study in healthy subjects of the safety, tolerability and pharmacokinetics of ASLAN004, a novel IgG anti-IL-13 receptor alpha 1 Inhibitor Journal of Investigative Dermatology · 2021 · 1 citations
    9. A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA). Journal of Clinical Oncology · 2017 · 1 citations
    10. FGF signaling for hair cycle resting phase alleviates radiation alopecia Journal of Dermatological Science · 2016 · 1 citations
    11. 219 STAT5 activation in the dermal papilla is important for hair follicle growth phase induction, hair follicle regeneration and wound healing Journal of Investigative Dermatology · 2016 · 1 citations
    12. THU0301 A Phase II Trial of Retinoids on Lupus Nephritis in A Single Center Annals of the rheumatic diseases · 2016 · 1 citations
    13. Telogen Phase of Hair Growth Cycle Is Regulated by Cyclic Epithelial FGF18 Signaling Journal of Dermatological Science · 2012 · 1 citations
    14. Scientific Opinion on the substantiation of a health claim related to spermidine and prolongation of the growing phase (anagen) of the hair cycle pursuant to Article 13(5) of Regulation (EC) No 1924/2006 EFSA Journal · 2011 · 1 citations
    15. In vivo Pharmacokinetic Interactions of Finasteride and Identification of Novel Metabolites 2010 · 1 citations
    16. Exploring mechanisms of the Ligusticum chuanxiong Hort. and Angelica sinensis (Oliv.) Diels pair in seborrheic alopecia: An integrated data mining, network pharmacology, and experimental study Journal of Traditional Chinese Medical Sciences · 2026
    17. Local Pharmacokinetics and Tolerability of Topically‐Applied Bimatoprost to the Scalp of Male Patients With Androgenetic Alopecia Clinical and Translational Science · 2026
    18. Development and Evaluation of a Herbal Hair Serum Containing Tridax procumbens: An In Silico and Phyto pharmacological Study Future Journal of Pharmaceuticals and Health Sciences · 2026
    19. Transcriptomic profiling of dermal papilla cells across growth phases, hair follicle types, and sexes in cashmere goats Scientific Data · 2026
    20. A Review on Curcumin-Piperine Synergy in Alopecia: Phytochemical Profiling, Molecular Docking and Network Pharmacology Approaches Zenodo (CERN European Organization for Nuclear Research) · 2026
    21. A Review on Curcumin-Piperine Synergy in Alopecia: Phytochemical Profiling, Molecular Docking and Network Pharmacology Approaches Zenodo (CERN European Organization for Nuclear Research) · 2026
    22. Data from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer 2026
    23. A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer Cancer Research Communications · 2026
    24. Emerging pharmacotherapies for Androgenetic Alopecia Expert Opinion on Pharmacotherapy · 2026
    25. Exploring the mechanism of stigmasterol against androgenetic alopecia using geometry optimization, network pharmacology, molecular docking, and molecular dynamics studies Scientific Reports · 2026
    26. Health-related quality of life in mild-moderate patchy alopecia areata: Results from the first controlled Phase 2 clinical trial in this population with STS01 (dithranol/ProSilic) and challenges for the future medRxiv · 2026
    27. Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trial British Journal of Dermatology · 2026
    28. Systems pharmacology identifies dermal papilla–specific transcriptomic reversal of androgenetic alopecia by lithium–zinc pathway convergence Zenodo (CERN European Organization for Nuclear Research) · 2026
    29. Systems pharmacology identifies dermal papilla–specific transcriptomic reversal of androgenetic alopecia by lithium–zinc pathway convergence Zenodo (CERN European Organization for Nuclear Research) · 2026
    30. The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database MedBA Medicine · 2026